Sendtner
Jürgen Sendtner, Deutschland DE
Patent application number | Description | Published |
---|---|---|
20110162282 | Motor Vehicle Having a Mechanism for Moving a Panel or Door - The invention relates to a motor vehicle having a panel or door, which can be brought from a closed position into an open position against the force of gravity using at least one energy storage element and means coupled therewith for influencing the torsional moment provided on the panel or door by the at least one energy storage element, wherein the panel or door is rotatably supported about an axis of rotation, and wherein the torsional moment can be influenced by the means for influencing depending on the opening position of the panel or door. | 07-07-2011 |
Jürgen Sendtner, Denkendorf-Zandt DE
Patent application number | Description | Published |
---|---|---|
20110308166 | APPARATUS FOR SPRING-ASSISTED PIVOTING OF A LIFTGATE OR DOOR, AND METHOD FOR PRODUCING SUCH APPARATUS - An apparatus for spring-assisted pivoting a liftgate or door against gravity between a closed position and an open position includes a torsion bar spring system with springs arranged in parallel in a meander pattern and connected with one another in fixed rotative engagement. An outer bearing-torsion bar spring and another outer lever-torsion bar spring are each supported in a support bracket of a tracker. The lever-torsion bar spring is connected in fixed rotative engagement with a length-adjustable lever guided in a control cam of the tracker. A coupling rod configured for translatory movement engages with the length-adjustable lever for rotating a hinged lever associated with the liftgate or door. An adjusting device is connected with the bearing-torsion bar spring in fixed rotative engagement and can be variably locked relative to the support bracket. A method for producing such apparatus is also disclosed. | 12-22-2011 |
20120144646 | METHOD FOR THE INSTALLATION OF AN APPARATUS FOR SPRING-ASSISTED SWINGING OF A LIFTGATE OR DOOR IN A VEHICLE - An apparatus for spring-assisted swinging of a liftgate in opposition to the gravity force between a closed position and an open position in a vehicle includes a spring energy store and a tracker which is coupled to the spring energy store for influencing a torque generated by the spring energy store. The tracker includes a coupling rod for rotatable actuation of a hinge lever articulated to the vehicle body and operably connected to the liftgate. To install the apparatus the coupling rod is temporarily fixed in a defined position corresponding to an installation position of the liftgate. The liftgate is held in the open position or in an intermediate position above the installation position and the apparatus is placed in the vehicle. After lowering the liftgate from the open position or intermediate position into the installation position, the coupling rod is connected to the hinge lever and then released. | 06-14-2012 |
Jürgen Sendtner, Denkendorf-Zandt DE
Patent application number | Description | Published |
---|---|---|
20130091773 | POWER ACTUATED REAR GATE ARRANGEMENT - A power actuated rear gate arrangement for a vehicle includes at least one seat arranged in a rear area of the vehicle; a drive device for providing an external force, a rear gate which is pivotal between a closed position and an open position by the external force, detectors for detecting an occupation of the at least one seat, and control points for controlling the drive device, wherein the drive device is at least indirectly controllable from more than one of the control points, and wherein when the at least one seat is occupied less than all of the control points are authorized or activated for at least a pivoting of the rear gate from the open position to the closed position. | 04-18-2013 |
Michael Sendtner, Veitshoechheim DE
Patent application number | Description | Published |
---|---|---|
20090253628 | Use of PEGylated IGF-I variants for the treatment of neuromuscular disorders - The present invention relates to a pharmaceutical composition containing a PEGylated IGF-I variant derived from the wild-type human IGF-I amino acid sequence where one or two of the lysine amino acids at positions 27, 65, and 68 are altered to be a polar amino acid other than lysine and where the PEG is attached to at least one lysine residue. The invention also relates to methods for the treatment, prevention and/or delay of progression of neuromuscular disorders, in particular amyotrophic lateral sclerosis (ALS) by administering a therapeutically effective amount of the pharmaceutical composition of the invention. | 10-08-2009 |
20110183903 | USE OF PEGylated IGF-I VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS - The present invention relates to a pharmaceutical composition containing a PEGylated IGF-I variant derived from the wild-type human IGF-I amino acid sequence where one or two of the lysine amino acids at positions 27, 65, and 68 are altered to be a polar amino acid other than lysine and where the PEG is attached to at least one lysine residue. The invention also relates to methods for the treatment, prevention and/or delay of progression of neuromuscular disorders, in particular amyotrophic lateral sclerosis (ALS) by administering a therapeutically effective amount of the pharmaceutical composition of the invention. | 07-28-2011 |
Michael Sendtner, Veitschoechheim DE
Patent application number | Description | Published |
---|---|---|
20140073567 | USE OF PEGYLATED IGF-1 VARIANTS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS - The present invention relates to a pharmaceutical composition containing a PEGylated IGF-I variant derived from the wild-type human IGF-I amino acid sequence where one or two of the lysine amino acids at positions 27, 65, and 68 are altered to be a polar amino acid other than lysine and where the PEG is attached to at least one lysine residue. The invention also relates to methods for the treatment, prevention and/or delay of progression of neuromuscular disorders, in particular amyotrophic lateral sclerosis (ALS) by administering a therapeutically effective amount of the pharmaceutical composition of the invention. | 03-13-2014 |
Michael Sendtner, Veitschoecheim DE
Patent application number | Description | Published |
---|---|---|
20150273023 | Use of PEGylated IGF-I Variants For The Treatment Of Neuromuscular Disorders - The present invention relates to a pharmaceutical composition containing a PEGylated IGF-I variant derived from the wild-type human IGF-I amino acid sequence where one or two of the lysine amino acids at positions 27, 65, and 68 are altered to be a polar amino acid other than lysine and where the PEG is attached to at least one lysine residue. The invention also relates to methods for the treatment, prevention and/or delay of progression of neuromuscular disorders, in particular amyotrophic lateral sclerosis (ALS) by administering a therapeutically effective amount of the pharmaceutical composition of the invention. | 10-01-2015 |